Cogentin Related Published Studies
Well-designed clinical trials possibly related to Cogentin (Benztropine)
Double-blind maintenance safety and effectiveness findings from the Treatment of
Early-Onset Schizophrenia Spectrum (TEOSS) study. [2010]
Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study. [2008.11]
Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain. [2007.07]
Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response--a double-blind PET study in schizophrenia. [2007.06]
Efficacy of noradrenergic and serotonergic antidepressants in chronic back pain: a preliminary concentration-controlled trial. [2007.04]
A randomized controlled trial of olanzapine versus haloperidol in the treatment of primary negative symptoms and neurocognitive deficits in schizophrenia. [2007.03]
Levomepromazine versus chlorpromazine in treatment-resistant schizophrenia: a double-blind randomized trial. [2006.07]
Other research related to Cogentin (Benztropine)
Paralytic ileus requiring hospitalization secondary to high-dose antipsychotic polypharmacy and benztropine. [2011.03]
N-substituted benztropine analogs: selective dopamine transporter ligands with a fast onset of action and minimal cocaine-like behavioral effects. [2011.02]
Assessment of reinforcing effects of benztropine analogs and their effects on cocaine self-administration in rats: comparisons with monoamine uptake inhibitors. [2009.05]
The novel N-substituted benztropine analog GA2-50 possesses pharmacokinetic and pharmacodynamic profiles favorable for a candidate substitute medication for cocaine abuse. [2008.12]
Formulation and biopharmaceutical evaluation of transdermal patch containing benztropine. [2008.06.05]
Dopamine transport inhibitors based on GBR12909 and benztropine as potential medications to treat cocaine addiction. [2008.01.01]
Fatal exertional heat stroke in a patient receiving zuclopenthixol, quetiapine and benztropine. [2007.09]
Transport, metabolism, and in vivo population pharmacokinetics of the chloro benztropine analogs, a class of compounds extensively evaluated in animal models of drug abuse. [2007.01]
Benztropine pretreatment does not affect responses to acute cocaine administration in human volunteers. [2006.12]
Investigation of the potential pharmacokinetic and pharmaco-dynamic drug interaction between AHN 1-055, a potent benztropine analog used for cocaine abuse, and cocaine after dosing in rats using intracerebral microdialysis. [2006.07]
Other possibly related research studies
Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain. [2006.12.18]
Adverse extrapyramidal effects in four horse given fluphenazine decanoate. [2006.07.01]
Adjunctive topiramate in ultradian cycling bipolar disorder: case report with 3-year follow-up. [2006.06]
Incidence of delirium in older adults newly prescribed lithium or valproate: a population-based cohort study. [2005.04]
Priapism associated with the switch from oral to injectable risperidone. [2006.12]
Dopamine transporter ligands: recent developments and therapeutic potential. [2006]
Polypharmacy in a 75-year-old patient with schizoaffective disorder. [2006.03]
Alternatives to levodopa in the initial treatment of early Parkinson's disease. [2005]
Antidepressant-induced sweating. [2005.04]
Possible intranasal quetiapine misuse. [2007.04.01]
Polypharmacy and EPS in a child; a case report. [2007]
The reliability and validity of the Test of Adaptive Behavior in Schizophrenia (TABS). [2007.05.30]
Rivastigmine-induced dystonia. [2007.12.01]
Role of calcium-independent phospholipase A2 in cortex striatum thalamus cortex circuitry-enzyme inhibition causes vacuous chewing movements in rats. [2007.12]
Azacitidine-associated hyperthermia and interstitial pneumonitis in a patient with myelodysplastic syndrome. [2007.12]
Transient tardive dystonia: overview and case presentation. [2008.07]
Pharmacogenetics of parkinsonism, rigidity, rest tremor, and bradykinesia in African-Caribbean inpatients: differences in association with dopamine and serotonin receptors. [2008.09.05]
Dextromethorphan-induced serotonin syndrome. [2008.09]
Toxicity from modafinil ingestion. [2009.02]
Double-blind maintenance safety and effectiveness findings from the Treatment of Early-Onset Schizophrenia Spectrum (TEOSS) study. [2010.06]
A dopamine transport inhibitor with markedly low abuse liability suppresses cocaine self-administration in the rat. [2009.12]
The dopamine uptake inhibitor 3 alpha-[bis(4'-fluorophenyl)metoxy]-tropane reduces cocaine-induced early-gene expression, locomotor activity, and conditioned reward. [2009.11]
Discovery of drugs to treat cocaine dependence: behavioral and neurochemical effects of atypical dopamine transport inhibitors. [2009]
Immediate-release oxybutynin for the treatment of clozapine-induced sialorrhea. [2011.09]
Improvement in drug-induced parkinsonism with electroconvulsive therapy. [2011.06]
Utilization of anti-Parkinson drugs in Australia: 1995-2009. [2011.05]
Synergism of theophylline and anticholinergics to inhibit haloperidol-induced catalepsy: a potential treatment for extrapyramidal syndromes. [2010.12.01]
Interventions for drooling in children with cerebral palsy. [2012]
|